MyAllies NewsBreakingRegulatoryWorldTechnologyBusinessPoliticsEntertainmentHealthSportsTopics
Home › Regulatory

Eton Pharmaceuticals, Inc. - 10-Q Filing

Eton Pharmaceuticals reports Q3 2026 financial results including updates on Impavido licensing and Selenix DS200 agreements.

3 articles from 1 source · updated November 5, 2026, 21:44 UTC

Coverage

  • Amphastar Pharmaceuticals, Inc. - 10-Q Filing SEC EDGAR · November 5, 2026, 21:40 UTC
  • Eton Pharmaceuticals, Inc. - 10-Q Filing SEC EDGAR · November 5, 2026, 21:32 UTC
  • LB PHARMACEUTICALS INC - 10-Q Filing SEC EDGAR · November 5, 2026, 21:32 UTC